CISN - Ethics - The Promise
| You Are Here: Home > Personalized Medicine > Ethics > The Promise |
EthicsThe PromiseThe overarching promise of personalized medicine is to optimize medical care and outcomes for each individual. It recognizes that the best treatments, medications, dosages, and preventive strategies may differ from person to person--resulting in customized patient care. Personalized medicine takes into consideration that all human diseases have both molecular and environmental components. The study of genetic variation has proven to be more complex than previously imagined, but is steadily moving forward. Proteomics and Metabolomics are still in the early stages of study and are not yet used routinely in the clinic, but the potential is great. Traditional Care ModelTraditionally, during a doctors visit, patients would explain their symptoms, answer questions concerning their past and present medical history, report their family medical history, and in some cases may undergo diagnostic procedures, such as x-rays and blood tests. Patient diagnosis and treatment are determined based on clinical presentation, medical history, lifestyle factors, and test results. Future Care ModelPersonalized medicine is an evolving model of healthcare delivery that determines appropriate treatments based on each patients unique characteristics. A significant difference between personalized medicine and the traditional model of care is the use of an individuals genomic information, where molecular data is used to determine appropriate treatments. (Steele, 2009). Expected Improvements The current model of bringing a drug from the bench to the bedside is slow and costly (Rochman, 2012). With increasing understanding of the human genome and the molecular level of disease, there is increasing potential for more efficient, effective methods to successfully treat the right patients with the right therapies at the right time. |
| Personalized Medicine & You |
|
| Understanding Tissue Issues |
|
| Ethics | |
| Molecular Diagnostics |
|
|
|1 2 | |
